ARK Clinical Research is a clinical research site located in Long Beach, California, United States 90806.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
ARK Clinical Research has participated in 6 clinical trials with 3 currently active.
Therapeutic areas: Respiratory Syncytial Virus Infections, Overactive Bladder Syndrome, Metabolic Dysfunction Associated Steatohepatitis (MASH).
Sponsors: Bavarian Nordic, Imbrium Therapeutics, Boehringer Ingelheim.
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
ARK Clinical Research has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
ARK Clinical Research has 6 clinical trials on record, with 3 currently active. Their work covers Respiratory Syncytial Virus Infections, Overactive Bladder Syndrome, Metabolic Dysfunction Associated Steatohepatitis (MASH).
Yes — ARK Clinical Research holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.